Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 375

1.

Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component.

Hsu KC, Pinto-Agnello C, Gooley T, Malkki M, Dupont B, Petersdorf EW.

Tissue Antigens. 2007 Apr;69 Suppl 1:42-5.

PMID:
17445161
2.

KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.

Hsu KC, Gooley T, Malkki M, Pinto-Agnello C, Dupont B, Bignon JD, Bornhäuser M, Christiansen F, Gratwohl A, Morishima Y, Oudshoorn M, Ringden O, van Rood JJ, Petersdorf E; International Histocompatibility Working Group.

Biol Blood Marrow Transplant. 2006 Aug;12(8):828-36.

3.

Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.

Gagne K, Busson M, Bignon JD, Balère-Appert ML, Loiseau P, Dormoy A, Dubois V, Perrier P, Jollet I, Bois M, Masson D, Moine A, Absi L, Blaise D, Charron D, Raffoux C; ARS2000 FRM and FGM group.

Biol Blood Marrow Transplant. 2009 Nov;15(11):1366-75. doi: 10.1016/j.bbmt.2009.06.015.

4.

The role of missing killer cell immunoglobulin-like receptor ligands in T cell replete peripheral blood stem cell transplantation from HLA-identical siblings.

Clausen J, Kircher B, Auberger J, Schumacher P, Ulmer H, Hetzenauer G, Wolf D, Gastl G, Nachbaur D.

Biol Blood Marrow Transplant. 2010 Feb;16(2):273-80. doi: 10.1016/j.bbmt.2009.10.021. Epub 2009 Oct 24.

6.

Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation.

Shilling HG, McQueen KL, Cheng NW, Shizuru JA, Negrin RS, Parham P.

Blood. 2003 May 1;101(9):3730-40. Epub 2003 Jan 2.

7.

The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.

Farag SS, Bacigalupo A, Eapen M, Hurley C, Dupont B, Caligiuri MA, Boudreau C, Nelson G, Oudshoorn M, van Rood J, Velardi A, Maiers M, Setterholm M, Confer D, Posch PE, Anasetti C, Kamani N, Miller JS, Weisdorf D, Davies SM; KIR Study Group, Center for International Blood and Marrow Transplantation Research.

Biol Blood Marrow Transplant. 2006 Aug;12(8):876-84.

8.

The effect of natural killer cell killer Ig-like receptor alloreactivity on the outcome of bone marrow stem cell transplantation for severe combined immunodeficiency (SCID).

Keller MD, Chen DF, Condron SA, Liu N, Reinsmoen NL, Buckley RH.

J Clin Immunol. 2007 Jan;27(1):109-16. Epub 2006 Dec 27. Erratum in: J Clin Immunol. 2007 Nov;27(6):659.

PMID:
17191149
9.

Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.

Hsu KC, Keever-Taylor CA, Wilton A, Pinto C, Heller G, Arkun K, O'Reilly RJ, Horowitz MM, Dupont B.

Blood. 2005 Jun 15;105(12):4878-84. Epub 2005 Feb 24.

10.

Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor.

Fischer JC, Ottinger H, Ferencik S, Sribar M, Punzel M, Beelen DW, Schwan MA, Grosse-Wilde H, Wernet P, Uhrberg M.

J Immunol. 2007 Mar 15;178(6):3918-23.

11.

Relevance of KIR gene matching in unrelated hematopoietic stem cell transplantations.

Gagne K, Busson M, Balere-Appert ML, Absi L, Jollet I, Bignon JD, Bois M, Dormoy A, Dubois V, Gebuhrer L, Loiseau P, Masson D, Moine A, Perrier P, Reviron D, Charron D, Raffoux C; ARS 2000 FRM and FGM group.

Tissue Antigens. 2007 Apr;69 Suppl 1:118-22.

PMID:
17445183
12.
13.

Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor.

Davies SM, Ruggieri L, DeFor T, Wagner JE, Weisdorf DJ, Miller JS, Velardi A, Blazar BR.

Blood. 2002 Nov 15;100(10):3825-7. Epub 2002 Jul 5.

14.

Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor.

Morishima Y, Yabe T, Matsuo K, Kashiwase K, Inoko H, Saji H, Yamamoto K, Maruya E, Akatsuka Y, Onizuka M, Sakamaki H, Sao H, Ogawa S, Kato S, Juji T, Sasazuki T, Kodera Y; Japan Marrow Donor Program.

Biol Blood Marrow Transplant. 2007 Mar;13(3):315-28.

15.

Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors.

Giebel S, Locatelli F, Lamparelli T, Velardi A, Davies S, Frumento G, Maccario R, Bonetti F, Wojnar J, Martinetti M, Frassoni F, Giorgiani G, Bacigalupo A, Holowiecki J.

Blood. 2003 Aug 1;102(3):814-9. Epub 2003 Apr 10.

16.

The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.

Bishara A, De Santis D, Witt CC, Brautbar C, Christiansen FT, Or R, Nagler A, Slavin S.

Tissue Antigens. 2004 Mar;63(3):204-11.

PMID:
14989709
17.

Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.

de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F.

Liver Transpl. 2009 Apr;15(4):390-9. doi: 10.1002/lt.21673.

18.

KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.

Ludajic K, Balavarca Y, Bickeböller H, Rosenmayr A, Fae I, Fischer GF, Kouba M, Pohlreich D, Kalhs P, Greinix HT.

Bone Marrow Transplant. 2009 Jul;44(2):97-103. doi: 10.1038/bmt.2008.432. Epub 2009 Jan 26.

PMID:
19169284
19.
20.

Expansion of NKG2A-LIR1- natural killer cells in HLA-matched, killer cell immunoglobulin-like receptors/HLA-ligand mismatched patients following hematopoietic cell transplantation.

Rathmann S, Glatzel S, Schönberg K, Uhrberg M, Follo M, Schulz-Huotari C, Kaymer M, Veelken H, Finke J, Fisch P.

Biol Blood Marrow Transplant. 2010 Apr;16(4):469-81. doi: 10.1016/j.bbmt.2009.12.008. Epub 2010 Jan 4.

Supplemental Content

Support Center